Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CTS.TO Stock Summary
Top 10 Correlated ETFs
CTS.TO
In the News
CTS.TO Financial details
Company Rating
Strong Buy
Market Cap
860.27M
Income
-13.37M
Revenue
2.47B
Book val./share
2.85
Cash/share
0.51
Dividend
0.02
Dividend %
0.48%
Employees
-
Optionable
No
Shortable
Yes
Earnings
14 Nov 2023
P/E
-63.52
Forward P/E
23
PEG
3.71
P/S
0.34
P/B
1.45
P/C
8.12
P/FCF
6.43
Quick Ratio
0.9
Current Ratio
1.09
Debt / Equity
0.71
LT Debt / Equity
0.67
-
-
EPS (TTM)
-0.06
EPS next Y
0.18
EPS next Q
0.16
EPS this Y
44.44%
EPS next Y
-377.69%
EPS next 5Y
-427.61%
EPS last 5Y
NAN%
Revenue last 5Y
36.36%
Revenue Q/Q
6.65%
EPS Q/Q
-48.24%
-
-
-
-
SMA20
50.18%
SMA50
39.46%
SMA100
29.75%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-2%
ROC
0.04%
Gross Margin
28%
Oper. Margin
2%
Profit Margin
-1%
Payout
-31%
Shs Outstand
204.34M
Shs Float
192.73M
-
-
-
-
Target Price
-
52W Range
2.245-6.23
52W High
-31%
52W Low
+107%
RSI
76.55
Rel Volume
0.67
Avg Volume
464.86K
Volume
311.04K
Perf Week
3.5%
Perf Month
62.99%
Perf Quarter
18.29%
Perf Half Y
15.97%
-
-
-
-
Beta
1.81
-
-
Volatility
0.03%, 0.62%
Prev Close
0.73%
Price
4.14
Change
-0.72%
CTS.TO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.14 | 8.88 | 9.22 | 8.22 | 10.16 | |
Net income per share | -0.28 | -0.14 | -0.04 | 0.09 | 0.11 | |
Operating cash flow per share | 0.02 | 0.35 | 0.5 | 0.47 | 0.2 | |
Free cash flow per share | -0.02 | 0.32 | 0.45 | 0.43 | 0.08 | |
Cash per share | 0.16 | 0.27 | 0.63 | 1.34 | 0.75 | |
Book value per share | -0.07 | -0.13 | 0.99 | 3.3 | 2.82 | |
Tangible book value per share | -1.29 | -2.35 | -1.14 | 0.49 | -1.86 | |
Share holders equity per share | -0.07 | -0.13 | 0.99 | 3.3 | 2.82 | |
Interest debt per share | 1.49 | 2.14 | 1.54 | 0.05 | 2.07 | |
Market cap | 35.38M | 108.38M | 511.66M | 2.02B | 978.15M | |
Enterprise value | 113.39M | 253.22M | 586.06M | 1.77B | 1.24B | |
P/E ratio | -1.94 | -10 | -122.55 | 126.66 | 42.82 | |
Price to sales ratio | 0.08 | 0.16 | 0.54 | 1.32 | 0.45 | |
POCF ratio | 33.13 | 4.04 | 9.91 | 23.2 | 23.52 | |
PFCF ratio | -29.29 | 4.33 | 10.98 | 25.01 | 55.44 | |
P/B Ratio | -7.86 | -10.97 | 5.03 | 3.29 | 1.63 | |
PTB ratio | -7.86 | -10.97 | 5.03 | 3.29 | 1.63 | |
EV to sales | 0.25 | 0.37 | 0.62 | 1.16 | 0.57 | |
Enterprise value over EBITDA | 12.67 | 7.08 | 11.39 | 20.22 | 8.21 | |
EV to operating cash flow | 106.17 | 9.44 | 11.36 | 20.36 | 29.82 | |
EV to free cash flow | -93.87 | 10.13 | 12.57 | 21.95 | 70.28 | |
Earnings yield | -0.52 | -0.1 | -0.01 | 0.01 | 0.02 | |
Free cash flow yield | -0.03 | 0.23 | 0.09 | 0.04 | 0.02 | |
Debt to equity | -19.65 | -16.75 | 1.37 | 0 | 0.7 | |
Debt to assets | 0.35 | 0.34 | 0.19 | 0 | 0.19 | |
Net debt to EBITDA | 8.72 | 4.05 | 1.45 | -2.82 | 1.73 | |
Current ratio | 0.69 | 0.65 | 0.84 | 1.32 | 0.78 | |
Interest coverage | 0.26 | 0 | 1.24 | 6.17 | 3.57 | |
Income quality | -0.06 | -2.47 | -12.36 | 5.32 | 1.82 | |
Dividend Yield | 0 | 0 | 2.18 | 0 | 0 | |
Payout ratio | 0 | 0 | -267.63 | 0 | 0.05 | |
Sales general and administrative to revenue | 0.16 | 0.2 | 0.19 | 0.17 | 0.19 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.31 | 0.35 | 0.3 | 0.41 | 0.46 | |
Capex to operating cash flow | -2.13 | -0.07 | -0.1 | -0.07 | -0.58 | |
Capex to revenue | 0 | 0 | -0.01 | 0 | -0.01 | |
Capex to depreciation | -0.33 | -0.1 | -0.18 | -0.16 | -0.3 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.67 | 0.63 | 0.95 | 2.52 | 2.61 | |
ROIC | 0.03 | 0.1 | 0.17 | 0.05 | 0.08 | |
Return on tangible assets | -0.1 | -0.03 | -0.01 | 0.02 | 0.02 | |
Graham Net | -2.28 | -3.89 | -2.54 | -0.58 | -3.72 | |
Working capital | -73.86M | -158.03M | -94.23M | 189.49M | -309.63M | |
Tangible asset value | -83.15M | -182.2M | -117.25M | 91.96M | -396.79M | |
Net current asset value | -97.95M | -211.58M | -141.55M | 60.7M | -489.79M | |
Invested capital | -19.65 | -16.75 | 1.37 | 0 | 0.7 | |
Average receivables | 86.8M | 175.06M | 292.22M | 390.4M | 599.09M | |
Average payables | 93.65M | 192.21M | 323.11M | 458.72M | 672.18M | |
Average inventory | 11.78M | 17.88M | 30.62M | 71.06M | 131.34M | |
Days sales outstanding | 103.32 | 116.82 | 140.15 | 99.5 | 131.81 | |
Days payables outstanding | 134.65 | 172.17 | 202.95 | 160.38 | 186.57 | |
Days of inventory on hand | 12.25 | 16.21 | 19.31 | 32.19 | 35.83 | |
Receivables turnover | 3.53 | 3.12 | 2.6 | 3.67 | 2.77 | |
Payables turnover | 2.71 | 2.12 | 1.8 | 2.28 | 1.96 | |
Inventory turnover | 29.8 | 22.51 | 18.9 | 11.34 | 10.19 | |
ROE | 4.05 | 1.1 | -0.04 | 0.03 | 0.04 | |
Capex per share | -0.04 | -0.02 | -0.05 | -0.03 | -0.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.86 | 1.98 | 3.25 | 3.2 | 3.46 | |
Net income per share | 0.1 | -0.02 | -0.02 | -0.02 | -0.01 | |
Operating cash flow per share | 0.07 | 0.14 | 0.14 | -0.05 | 0.47 | |
Free cash flow per share | 0.05 | 0.12 | 0.11 | -0.06 | 0.46 | |
Cash per share | 0.82 | 0.76 | 0.67 | 0.38 | 0.51 | |
Book value per share | 2.88 | 2.86 | 2.89 | 2.81 | 2.85 | |
Tangible book value per share | -1.5 | -1.89 | -1.82 | -1.76 | -1.74 | |
Share holders equity per share | 2.88 | 2.86 | 2.89 | 2.81 | 2.85 | |
Interest debt per share | 1.79 | 2.05 | 2.25 | 2.12 | 2.07 | |
Market cap | 1.38B | 963.2M | 852.6M | 666.66M | 570.11M | |
Enterprise value | 1.58B | 1.23B | 1.17B | 1.02B | 877.64M | |
P/E ratio | 16.81 | -51.73 | -63.42 | -46.97 | -79.09 | |
Price to sales ratio | 2.3 | 2.32 | 1.26 | 1 | 0.8 | |
POCF ratio | 92.61 | 31.69 | 29.64 | -69.12 | 5.94 | |
PFCF ratio | 130.39 | 38.11 | 36.04 | -56.8 | 6.04 | |
P/B Ratio | 2.28 | 1.61 | 1.41 | 1.14 | 0.97 | |
PTB ratio | 2.28 | 1.61 | 1.41 | 1.14 | 0.97 | |
EV to sales | 2.63 | 2.95 | 1.73 | 1.53 | 1.24 | |
Enterprise value over EBITDA | 30.53 | 32.13 | 32.08 | 25.2 | 21.85 | |
EV to operating cash flow | 105.95 | 40.3 | 40.81 | -105.6 | 9.15 | |
EV to free cash flow | 149.17 | 48.48 | 49.62 | -86.79 | 9.3 | |
Earnings yield | 0.01 | 0 | 0 | -0.01 | 0 | |
Free cash flow yield | 0.01 | 0.03 | 0.03 | -0.02 | 0.17 | |
Debt to equity | 0.61 | 0.7 | 0.76 | 0.73 | 0.71 | |
Debt to assets | 0.18 | 0.19 | 0.21 | 0.2 | 0.19 | |
Net debt to EBITDA | 3.84 | 6.87 | 8.78 | 8.71 | 7.66 | |
Current ratio | 0.84 | 0.78 | 0.78 | 1.12 | 1.09 | |
Interest coverage | 4.72 | 1.78 | 0.97 | 1.05 | 0.79 | |
Income quality | 0.82 | -6.53 | -8.56 | 2.15 | -28.93 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | -0.58 | -1.14 | |
Sales general and administrative to revenue | 0.19 | 0.31 | 0.2 | 0.17 | 0.19 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.47 | 0.46 | 0.46 | 0.46 | 0.45 | |
Capex to operating cash flow | -0.29 | -0.17 | -0.18 | 0.22 | -0.02 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | 0 | 0 | |
Capex to depreciation | -0.18 | -0.23 | -0.19 | -0.07 | -0.05 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.52 | 1.19 | 1.02 | 1.04 | 0.75 | |
ROIC | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | 0.02 | 0 | 0 | 0 | 0 | |
Graham Net | -3.08 | -3.78 | -3.72 | -3.64 | -3.69 | |
Working capital | -185.3M | -309.63M | -309.87M | 112.51M | 89.25M | |
Tangible asset value | -317.02M | -396.79M | -380.98M | -365.78M | -356.58M | |
Net current asset value | -382.39M | -489.79M | -472.94M | -457.38M | -447.64M | |
Invested capital | 0.61 | 0.7 | 0.76 | 0.73 | 0.71 | |
Average receivables | 617.62M | 709.72M | 782.89M | 782.71M | 792.5M | |
Average payables | 667.06M | 755.78M | 826.46M | 821.43M | 856.64M | |
Average inventory | 141.52M | 161.1M | 158.02M | 159.01M | 163.1M | |
Days sales outstanding | 95.16 | 169.62 | 104.05 | 105.61 | 101.86 | |
Days payables outstanding | 133.31 | 302.01 | 147.1 | 149.62 | 150.85 | |
Days of inventory on hand | 31.8 | 58 | 28 | 29.45 | 27.84 | |
Receivables turnover | 0.95 | 0.53 | 0.86 | 0.85 | 0.88 | |
Payables turnover | 0.68 | 0.3 | 0.61 | 0.6 | 0.6 | |
Inventory turnover | 2.83 | 1.55 | 3.21 | 3.06 | 3.23 | |
ROE | 0.03 | -0.01 | -0.01 | -0.01 | 0 | |
Capex per share | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 |
CTS.TO Frequently Asked Questions
What is Converge Technology Solutions Corp. stock symbol ?
Converge Technology Solutions Corp. is a CA stock , located in Toronto of On and trading under the symbol CTS.TO
What is Converge Technology Solutions Corp. stock quote today ?
Converge Technology Solutions Corp. stock price is $4.14 today.
Is Converge Technology Solutions Corp. stock public?
Yes, Converge Technology Solutions Corp. is a publicly traded company.